Lanton Law Quoted in Bloomberg Law

life scienceshealthcare
Written By Ron Lanton

We have been talking a lot lately about drug pricing; specifically Most Favored Nation (MFN) and other ancillary issues. We were recently quoted in Bloomberg Law News on the issue here. Thanks to Nyah Phengsitthy for reaching out.

Ron Lanton
Previous

Lanton Law Returns to Moderate Most Favored Nation Panel for Pharmacy Times
Next

Lanton Law Moderates Most Favored Nation Panel for MJH Life Sciences